
Sign up to save your podcasts
Or


In this episode, I analyze the impact of Nvidia's substantial investment of $50 million in Recursion, discussing its role in advancing AI-driven drug discovery and its implications for the pharmaceutical industry.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
By Building AIIn this episode, I analyze the impact of Nvidia's substantial investment of $50 million in Recursion, discussing its role in advancing AI-driven drug discovery and its implications for the pharmaceutical industry.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.